Sitting Down With… Bobby Sheng, Chairman and CEO of Bora Pharmaceuticals, Taiwan.

In under two months, the ISCT managed to pull together a gamified virtual conference platform.

From patient recruitment to distributing products, we ask how clinical trials can weather the COVID-19 pandemic.

Why finding new talent is crucial to the success of the cell and gene therapy industry.

Will West and Schott’s collaboration pave the way for more vendor-to-vendor partnerships?

Sitting Down With… Frédéric Triebel, Co-Founder, Chief Scientific Officer, and Chief Medical Officer of Immutep, France.

Intel shows a rise in cell and gene therapy development in the US, with China not far behind.

Tackling solid tumors with macrophages, a stem cell cure for HIV, and travel bans… What’s new in advanced medicine?

In what may have been one of the last advanced therapy meetings to go ahead for some time, delegates met in London in late February for CAR-TCR.

The world’s largest cell and gene CDMO, an exciting new TCR, and the global CAR T picture… We examine what’s going on in advanced medicine.